153 related articles for article (PubMed ID: 21054477)
21. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
[TBL] [Abstract][Full Text] [Related]
22. Prediction of genetic risk for metabolic syndrome.
Yamada Y; Kato K; Hibino T; Yokoi K; Matsuo H; Segawa T; Watanabe S; Ichihara S; Yoshida H; Satoh K; Nozawa Y
Atherosclerosis; 2007 Apr; 191(2):298-304. PubMed ID: 16806226
[TBL] [Abstract][Full Text] [Related]
23. Association of apolipoprotein A1 and A5 polymorphisms with stroke subtypes in Han Chinese people in Taiwan.
Hsu LC; Hsu LS; Lee TH
Gene; 2019 Feb; 684():76-81. PubMed ID: 30367981
[TBL] [Abstract][Full Text] [Related]
24. Association study of Apolipoprotein A5 gene (APOA5 gene) variant with the metabolic syndrome in local Pakistani population.
Fiaz M; Shaiq PA; Raj GK; Saqlain M; Mehmood A; Naqvi SMS; Cheung BK
J Pak Med Assoc; 2019 Mar; 69(3):301-305. PubMed ID: 30890818
[TBL] [Abstract][Full Text] [Related]
25. Association between polymorphisms in MTHFR and APOA5 and metabolic syndrome in the Greek population.
Vasilopoulos Y; Sarafidou T; Bagiatis V; Skriapa L; Goutzelas Y; Pervanidou P; Lazopoulou N; Chrousos GP; Mamuris Z
Genet Test Mol Biomarkers; 2011 Sep; 15(9):613-7. PubMed ID: 21473680
[TBL] [Abstract][Full Text] [Related]
26. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents.
Zhu WF; Wang CL; Liang L; Shen Z; Fu JF; Liu PN; Lv LQ; Zhu YM
Lipids Health Dis; 2014 Jun; 13():93. PubMed ID: 24903888
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
[TBL] [Abstract][Full Text] [Related]
28. Association between apolipoprotein A5 - 1131T > C polymorphism and susceptibility of coronary artery disease in Chinese.
Tang YB; Sun P; Guo DP; Li XY; Chen Q; Fan LM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):281-3. PubMed ID: 15952115
[TBL] [Abstract][Full Text] [Related]
29. Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men.
Son KY; Son HY; Chae J; Hwang J; Jang S; Yun JM; Cho B; Park JH; Kim JI
Lipids Health Dis; 2015 Sep; 14():105. PubMed ID: 26365620
[TBL] [Abstract][Full Text] [Related]
30. Influences of APOA5 variants on plasma triglyceride levels in Uyghur population.
Li S; Hu B; Wang Y; Wu D; Jin L; Wang X
PLoS One; 2014; 9(10):e110258. PubMed ID: 25313938
[TBL] [Abstract][Full Text] [Related]
31. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population.
Matsunaga A; Arishima H; Niimura H; Zhang B; Uehara Y; Ohwaki K; Morita M; Hayashida K; Saku K
Circ J; 2007 May; 71(5):746-52. PubMed ID: 17457003
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
Zaki M; Amr K
Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
[TBL] [Abstract][Full Text] [Related]
33. Association of apolipoprotein A5 genetic polymorphisms with steroid-induced osteonecrosis of femoral head in a Chinese Han population.
Cui Y; Kaisaierjiang A; Cao P; Wu ZY; Lv Q
Diagn Pathol; 2014 Dec; 9():229. PubMed ID: 25515090
[TBL] [Abstract][Full Text] [Related]
34. Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people.
Yamada Y; Ichihara S; Kato K; Yoshida T; Yokoi K; Matsuo H; Watanabe S; Metoki N; Yoshida H; Satoh K; Aoyagi Y; Yasunaga A; Park H; Tanaka M; Lee W; Nozawa Y
J Med Genet; 2008 Jan; 45(1):22-8. PubMed ID: 17766366
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemia.
Hu M; Mak VW; Tomlinson B
J Clin Lipidol; 2012; 6(6):585-92. PubMed ID: 23312054
[TBL] [Abstract][Full Text] [Related]
36. Effects of apolipoprotein A5 haplotypes on the ratio of triglyceride to high-density lipoprotein cholesterol and the risk for metabolic syndrome in Koreans.
Cha S; Yu H; Park AY; Song KH
Lipids Health Dis; 2014 Mar; 13():45. PubMed ID: 24618354
[TBL] [Abstract][Full Text] [Related]
37. Genetic Association of Apolipoprotein A5-1131T>C Polymorphism with Traits of Metabolic Syndrome.
Zafar U; Khaliq S; Lone KP
J Coll Physicians Surg Pak; 2019 Jul; 29(7):626-630. PubMed ID: 31253212
[TBL] [Abstract][Full Text] [Related]
38. Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-Analysis.
Ye H; Zhou A; Hong Q; Tang L; Xu X; Xin Y; Jiang D; Dai D; Li Y; Wang DW; Duan S
PLoS One; 2015; 10(8):e0135683. PubMed ID: 26309253
[TBL] [Abstract][Full Text] [Related]
39. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
You Y; Wu YH; Zhang Y; Zhang L; Song Y; Bai W; Li Y; Yu Y; Kou C
BMJ Open; 2018 Jun; 8(6):e020016. PubMed ID: 29866721
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
Yin RX; Li YY; Lai CQ
Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
